Interestingly a previous study found that in 30 out of 41 prostate cancer patients, PSA values in CCL2 positive patients were significantly higher than in CCL2 negative patients, but when taking into account the entire cohort, they found no significant association [28]. This evidence concerns the gene KLK3 and prostate carcinoma.